Canada/Ottawa: Health Canada issues safety warning for Invokana (Canagliflozin) and Invokamet (Canagliflozin and Metformin) due to apparent increased risk of lower limb amputation. HCSC: http://ht.ly/b0sE30eYLmN
Direct link: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/64366a-eng.php
Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following prescription drugs are subject to this safety warning:
Filed under: Amputation, Canagliflozin, Drugs, Invokamet, Invokana, Metformin | Tagged: diabetes, HCSC ID number: RA-64366, Health Canada/Santé Canada, increased risk of limb amputation, Invokamet, Invokana, Janssen Inc., Recalls Direct RIN: 9170-2017 | Leave a comment »